{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:40:37Z","timestamp":1791092437345,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.mce.2003.10.005","type":"journal-article","created":{"date-parts":[[2004,5,8]],"date-time":"2004-05-08T08:09:36Z","timestamp":1084003776000},"page":"27-31","source":"Crossref","is-referenced-by-count":165,"title":["The evolution of aldosterone antagonists"],"prefix":"10.1016","volume":"217","author":[{"given":"Susan M","family":"Garthwaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen G","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2003.10.005_BIB1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00500971","article-title":"Effect of enoterohepatic circulation on the pharmacokinetics of spironolactone in man","volume":"300","author":"Abshagen","year":"1977","journal-title":"Naunyn-schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.mce.2003.10.005_BIB2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2003.10.005_BIB3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI104429","article-title":"Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion","volume":"40","author":"Carpenter","year":"1961","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2003.10.005_BIB4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/jo01090a019","article-title":"Steroidal aldosterone blockers. II","volume":"24","author":"Cella","year":"1959","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.mce.2003.10.005_BIB5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/jo01088a004","article-title":"Steroidal aldosterone blockers. I","volume":"24","author":"Cella","year":"1959","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.mce.2003.10.005_BIB6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1124\/dmd.30.12.1344","article-title":"Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A and CYP3A5","volume":"30","author":"Cook","year":"2002","journal-title":"Drug Met. Dispos."},{"key":"10.1016\/j.mce.2003.10.005_BIB7","first-page":"1194","article-title":"Antiandrogenic effect of spirolactones: mechanism of action","volume":"104","author":"Corval","year":"1979","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.005_BIB8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/jcem-47-1-171","article-title":"SC-25152: A potent mineralocorticoid antagonist with reduced affinity for the 5\u03b1-dihydrotestosterone receptor of human and rat prostate","volume":"47","author":"Cutler","year":"1978","journal-title":"J. Clin. Endocrinal. Metab."},{"key":"10.1016\/j.mce.2003.10.005_BIB9","first-page":"144","article-title":"SC-25152: A potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone","volume":"209","author":"Cutler","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mce.2003.10.005_BIB10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1976.56.1.1","article-title":"Mechanisms regulating renin release","volume":"56","author":"Davis","year":"1976","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mce.2003.10.005_BIB11","first-page":"650","article-title":"Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"deGasparo","year":"1987","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.mce.2003.10.005_BIB12","doi-asserted-by":"crossref","first-page":"H647","DOI":"10.1152\/ajpheart.2001.281.2.H647","article-title":"Effect of a selective aldosterone receptor antagonist in myocardial infarction","volume":"281","author":"Delyani","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.mce.2003.10.005_BIB13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1527-3466.2001.tb00064.x","article-title":"Eplerenone: a selective aldosterone receptor antagonist (SARA)","volume":"19","author":"Delyani","year":"2001","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.mce.2003.10.005_BIB14","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/0006-2952(68)90203-7","article-title":"Mode of spirolactone action: competitive inhibition of aldosterone binding to kidney mineralocorticoid receptors","volume":"17","author":"Fanestil","year":"1968","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2003.10.005_BIB15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black patients and white patients","volume":"41","author":"Flack","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mce.2003.10.005_BIB16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0006-2952(74)90386-4","article-title":"Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors","volume":"23","author":"Funder","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2003.10.005_BIB17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.225.1.40","article-title":"Adverse reactions to spironolactone: a report from the Boston Collaborative Drug Surveillance Program","volume":"225","author":"Greenblatt","year":"1973","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.mce.2003.10.005_BIB18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cpt1978244465","article-title":"Gynecomastia induced in normal males by spironolactone","volume":"24","author":"Huffman","year":"1978","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.mce.2003.10.005_BIB19","first-page":"363","article-title":"Spirolactone inhibition of aldosterone induced nuclear RNA synthesis in toad urinary bladder","volume":"1","author":"Hutchinson","year":"1970","journal-title":"Res. Comm. Chem. Path. Pharm."},{"key":"10.1016\/j.mce.2003.10.005_BIB20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1126\/science.126.3281.1015","article-title":"Action of new steroids blocking effects of aldosterone and desoxycorticosterone on salt","volume":"126","author":"Kagawa","year":"1957","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mce.2003.10.005_BIB21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/03602537808993782","article-title":"Spironolactone: disposition, metabolism, pharmacodynamics and bioavailability","volume":"8","author":"Karim","year":"1978","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.mce.2003.10.005_BIB22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Addition of eplerenone to ACE inhibition or angiotensin blockade in hypertensive patients","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2003.10.005_BIB23","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jcem-15-10-1194","article-title":"The metabolic effects of progesterone in man","volume":"15","author":"Landau","year":"1952","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2003.10.005_BIB24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1471-4892(01)00022-4","article-title":"Recent studies with eplerenone, a novel selective aldosterone receptor antagonist","volume":"1","author":"McMahon","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.mce.2003.10.005_BIB25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1515\/DMDI.1987.5.4.273","article-title":"The metabolism and biopharmaceutics of spironolactone in man","volume":"5","author":"Overdiek","year":"1987","journal-title":"Drug Metab. Interact."},{"issue":"10","key":"10.1016\/j.mce.2003.10.005_BIB26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.mce.2003.10.005_BIB27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS Trial: eplerenone in patients with heat failure due to systolic dysfunction complicating acute myocardial infarction","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"14","key":"10.1016\/j.mce.2003.10.005_BIB28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.mce.2003.10.005_BIB29","first-page":"H1802","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2003.10.005_BIB30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3181\/00379727-104-25782","article-title":"Protection by a steroid-spirolactone against certain types of cardiac necroses","volume":"104","author":"Selye","year":"1960","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.mce.2003.10.005_BIB31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02155834","article-title":"Isolierung eines neuen kristallisierten hormons aus nebennieren mit besonderer hoher wirksamkeit auf den mineralstoff wechsel","volume":"9","author":"Simpson","year":"1953","journal-title":"Experientia"},{"key":"10.1016\/j.mce.2003.10.005_BIB32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/endo-64-2-299","article-title":"Prevention of adrenal-regeneration hypertension by an aldosterone-blocker","volume":"64","author":"Sturtevant","year":"1959","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.005_BIB33","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","article-title":"Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in dogs with heart failure","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.mce.2003.10.005_BIB34","first-page":"1331","article-title":"Satefy, tolerability and pharmacokinetics of eplerenone, a selective aldosterone blocker","volume":"22","author":"Tolbert","year":"2002","journal-title":"Pharmacokinetics"},{"key":"10.1016\/j.mce.2003.10.005_BIB35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF00544063","article-title":"Assessment of the antimineralocorticoid effect of RU 28 318 in healthy men with induced exogenous and endogenous hyper-mineralocorticism","volume":"28","author":"Ulmann","year":"1985","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.mce.2003.10.005_BIB36","unstructured":"United States Patent Office. 3,013,012, 1960. Alkanoylthio-17\u03b1-carboxyethyl-17\u03b2-hydroxyandrosten-3-one lactones. Ser. no. 77, 517."},{"issue":"8","key":"10.1016\/j.mce.2003.10.005_BIB37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild to moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.mce.2003.10.005_BIB38","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2003.10.005_BIB39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9149(03)00461-2","article-title":"Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension","volume":"92","author":"White","year":"2003","journal-title":"Am. J. Cardiol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720703003769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720703003769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T17:24:09Z","timestamp":1549733049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720703003769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0303720703003769"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2003.10.005","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}